Chemotherapy-induced Nausea and Vomiting Drugs Market Key Drivers and Forecast 2025-2032
Chemotherapy-induced Nausea and Vomiting Drugs Market Trends And Drivers Chemotherapy-induced nausea and vomiting (CINV) drugs market was valued at USD 3.92 Billion in 2022 and is projected to reach USD 6.34 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. The increasing prevalence of cancer globally, coupled with advancements in chemotherapy […]
Continue Reading